Cresco Labs Inc. CL CRLBF confirmed Friday the closing of its previously announced acquisition of Cultivate for $90 million.
Transaction Highlights
- Approximately 42,000 square feet of active flowering canopy, bringing combined canopy in-state to approximately 64,000 square feet. The transaction also includes space available to further expand cultivation capacity.
- Three operational dispensaries located in Leicester, Framingham and Worcester, bringing combined retail storefronts in-state to four. Concurrent with closing, the company’s Fall River retail location has transitioned to medical sales only.
- Greater operating platform to pursue market share growth in the largest adult-use cannabis market in the northeast. The Massachusetts’ market structure offers a unique opportunity to wholesalers given limited cultivation licenses, robust pricing and abundant retail stores throughout the state.
“The closing today constitutes another important step for Cresco Labs as we deepen our presence in large, attractive states like Massachusetts and increasingly tailor and strengthen our state-level strategies to optimize growth and profitability,” Charlie Bachtell, CEO and co-founder of Cresco Labs said. “Expanding operations in the most strategic U.S. cannabis markets is at the heart of our growth strategy and we’re thrilled to have the opportunity to show what can be achieved through a maximized footprint in Massachusetts. We have been thoroughly impressed with the Cultivate team and the quality of their operations. “
More recent news from Cresco Labs:
Price Action
Cresco Labs’ shares were trading 0.04% higher at $9.71 per share at the time of writing Friday morning.
Photo: Courtesy of Business Wire
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.